RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--March 28, 2006--Icagen, Inc. (NASDAQ: ICGN) today announced plans to webcast its Sickle Cell Disease Day Investor and Analyst Meeting scheduled for Friday, March 31, 2006 in New York City. During this meeting, Icagen will provide a review of the clinical and therapeutic aspects of sickle cell disease. The meeting will include presentations by two leading sickle cell disease physicians and by Icagen senior executives.
